NANOSYNEX
Nanosynex is a diagnostic test that checks bacterial resistance to antibiotics in a record time, using a phenotypic approach that involves microfluidic techniques and fluorescent-based analysis. The test helps doctors determine faster (same-day results) the most appropriate antibiotic treatment for their patients, helping them recover in a shorter time and preventing the spread of resistant bacteria in the environment. By limiting prolonged hospitalization, Nanosynex allows to save significant healthcare costs.
NANOSYNEX
Industry:
Biotechnology Health Care
Founded:
2017-02-09
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.nanosynex.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
83.35 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Nanosynex
MassChallenge
MassChallenge investment in Non Equity Assistance - Nanosynex
Newest Events participated
Official Site Inspections
http://www.nanosynex.com
- Host name: webacc13.sd5.ghst.net
- IP address: 155.133.138.15
- Location: Poland
- Latitude: 52.2394
- Longitude: 21.0362
- Timezone: Europe/Warsaw
More informations about "Nanosynex"
NanoSynex
NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes.See details»
About NanoSynex
NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic processes. Today, NanoSynex is …See details»
Nanosynex - Crunchbase Company Profile & Funding
Nanosynex is a microfluidic diagnostic test for early detection of bacterial infections. View contacts for Nanosynex to access new leads and connect with decision-makers.See details»
NanoSynex - LinkedIn
NanoSynex is a medtech startup focused on the urgent need of rapid diagnostics tests for bacterial susceptibility and resistance to antibiotics. Nanosynex solution is a bio-convergent system...See details»
NanoSynex Company Profile 2024: Valuation, Investors …
Developer of antimicrobial susceptibility tests designed to check bacterial resistance to antibiotics.See details»
NANOSYNEX LTD - VentureRadar
Oct 1, 2020 · Nanosynex is an Israeli MedTech startup created in 2017 that aims at providing new solutions to improve testing quality and reduce healthcare costs by speeding up diagnostic …See details»
MIT Solve | Nanosynex - Overview
Nanosynex is a biomedical startup developing a personalized diagnostic test that checks bacterial resistance to antibiotics in record time. Present your project. Antimicrobial Resistance (AMR) …See details»
Qualigen Takes Stake In NanoSynex To Gain Access To Next-Gen …
May 3, 2022 · Qualigen Therapeutics Inc (NASDAQ: QLGN) has agreed to acquire a majority stake in NanoSynex Ltd, an Israeli-based developer of next-generation diagnostics technology.See details»
Alumni Startup Joins Israeli Emergency Medical …
Nanosynex, an innovative medtech startup that traces its beginnings to Technion Professor Shulamit Levenberg’s lab, is now on the frontlines in Israel tackling the COVID-19 pandemic.See details»
Startup Fights Superbugs, Antibiotic Resistance With …
Jul 21, 2024 · To tackle this issue, Israeli medical technology startup NanoSynex has developed a rapid personalized diagnostic test, which will enable doctors to prescribe the correct antibiotics at the moment they are needed most.See details»
Qualigen Therapeutics to Acquire Majority Stake in - GlobeNewswire
May 3, 2022 · NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality, patient outcomes, and reduce healthcare costs by speeding up diagnostic …See details»
Nanosynex - Foreign Startup | Startup Nation Finder
Feb 3, 2020 · Nanosynex is a biotech startup developing solutions designed to improve testing quality and reduce healthcare costs by accelerating diagnostic processes. Nanosynex is …See details»
Qualigen Therapeutics Provides Update on Developments at …
Jan 5, 2023 · NanoSynex’s mission is to save lives by prescribing targeted antibiotics faster. NanoSynex aims to provide diagnostics that can help doctors make a smart choice by using …See details»
NanoSynex - Overview, News & Similar companies | ZoomInfo.com
Jun 1, 2022 · NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality, patient outcomes, and reduce healthcare costs by speeding up diagnostic …See details»
Israeli Diagnostics Firm NanoSynex Aiming for European Market …
Oct 23, 2020 · NanoSynex's EU Horizon 2020 project commenced on October 1 and will run through September 30, 2022. The company is the sole organization taking part in it. The grant …See details»
Nanosynex Aims to Bring Rapid COVID-19 Tests to Israel
Jan 21, 2021 · Nanosynex, a startup whose mission is to save lives by speeding up diagnostic processes, is working to bring a new inexpensive rapid testing kit that will successfully detect …See details»
Qualigen Therapeutics’ Partner NanoSynex to Present
Oct 5, 2022 · NanoSynex is a MedTech company that aims at providing new solutions to improve testing quality, patient outcomes, and reduce healthcare costs by speeding up diagnostic …See details»
Qualigen Therapeutics’ Partner NanoSynex to Present Technology …
May 10, 2022 · NanoSynex’s innovative technology is an Antimicrobial Susceptibility Testing (AST) platform that aims to provide clinical laboratories worldwide with a rapid, accurate and …See details»
Jonathan Avesar - Inventor & Scientist at Nanosynex | The Org
In 2018, Jonathan joined Nanosynex as an Inventor & Scientist, and in 2019, they joined Lever VC as a Scientific Advisor. Their work experience demonstrates their expertise and …See details»
Qualigen Therapeutics’ Partner NanoSynex to Present Industry …
NanoSynex is focused on the development and commercialization of a rapid innovative Antimicrobial Susceptibility Test (AST). The technology is based on a purely phenotypic …See details»